Kristine Mørch
Position
Head National Center for Tropical Infectious Diseases, Haukeland University Hospital
Affiliation
- kristine.morch@uib.no
- Phone number
- 004755975660
- Visitor address
-
Department of Medicine, Haukeland University Hospital
5021 Bergen - Postal address
-
P.O. Box 7804NO-5020 BergenNorway
Follow me
Kristine Mørch
Position
Head National Center for Tropical Infectious Diseases, Haukeland University Hospital
Affiliation
Research
Kristine Mørch, MD, PhD, is head of National Center for Tropical Infectious Diseases at Infectious Diseases Section, Department of Medicine, Haukeland university hospital. She is also associate professor at Department of Clinical Science, University of Bergen. Her main research interest is the field of tropical infectious diseases, particularly acute febrile diseases and malaria, as well as giardiasis with focus on resistance and treatment of metronidazol refractory infections.
Publications
Academic article
- Trygve Kristiansen; Sabrina John Moyo; Joel Manyahi et al. (2026). Antimicrobial resistance in paediatric bloodstream infections in Tanzania: a longitudinal comparison of two cohort studies. (external link)
- Tilman Lingscheid; Johannes Jochum; Pinkus Tober-Lau et al. (2025). Severe imported <i>Plasmodium falciparum</i> malaria with hyperparasitaemia: evaluation of determinants of critical disease in adult returning travellers. (external link)
- Sabrina John Moyo; Joel Manyahi; Said Aboud et al. (2025). Extended-spectrum-β-lactamase-producing Gram-negative bacteria are associated with high mortality in children with bloodstream infections in Dar es Salaam, Tanzania. (external link)
- Jahid Hasan Tipu; Kristine Mørch; Kurt Hanevik (2025). Visited India? Metronidazole may not cure your <i>Giardia</i> infection. (external link)
- Kurt Hanevik; Knut-Arne Wensaas; Guri Rørtveit et al. (2014). Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: A controlled prospective cohort study. (external link)
- Bjørn Blomberg; Trond Bruun; Stina Jordal et al. (2024). Ein mann i 60-åra med livstrugande febersjukdom etter utanlandsreise. (external link)
- Knut Erik Emberland; Knut-Arne Wensaas; Sverre Litleskare et al. (2021). Antibiotics for gastroenteritis in general practice and out-of-hours services in Norway 2006-15. (external link)
- Andreas Neumayr; Mirjam Schunk; Caroline Theunissen et al. (2021). Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study. (external link)
- Annette Onken; Christel Gill Haanshuus; Mohammed Khamis Miraji et al. (2022). Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar. (external link)
- Kristine Mørch; Kurt Hanevik; Ann Christin Rivenes et al. (2013). Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. (external link)
- Kurt Hanevik; Christina Skår Saghaug; Maren Aaland et al. (2022). No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection. (external link)
- Christel Gill Haanshuus; Stein Christian Mohn; Kristine Mørch et al. (2013). A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. (external link)
- Elisabeth Astrup Strand; Lucy J. Robertson; Kurt Hanevik et al. (2008). Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. (external link)
- Jesper Waldenström; Kristoffer Hellstrand; Johan Westin et al. (2021). Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. (external link)
- Christel Gill Haanshuus; Sara Chandy; Anand Manoharan et al. (2016). A high malaria prevalence identified by PCR among patients with acute undifferentiated fever in India. (external link)
- Christel Gill Haanshuus; Kristine Mørch; Bjørn Blomberg et al. (2019). Assessment of malaria real-time PCR methods and application with focus on lowlevel parasitaemia. (external link)
- Kristine Mørch; Kurt Hanevik (2020). Giardiasis treatment: an update with a focus on refractory disease. (external link)
- Kurt Hanevik; Kristine Mørch; Geir Egil Eide et al. (2008). Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: A randomized open clinical trial. (external link)
- Kurt Hanevik; Einar Klæboe Kristoffersen; Kristine Mørch et al. (2017). Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. (external link)
- Thomas Zoller; Thomas Junghanss; Annette Kapaun et al. (2011). Intravenous Artesunate for Severe Malaria in Travelers, Europe. (external link)
- Magnus Lindh; Martin Lagging; Martti Färkkilä et al. (2011). Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus. (external link)
- Kristine Mørch; Kurt Hanevik; Guri Rørtveit et al. (2009). High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. (external link)
- Mogens Jensenius; Kristine Mørch; Sheraz Yakub et al. (2024). Alveolær ekinokokkose. (external link)
- Florian Kurth; Michel Develoux; Matthieu Mechain et al. (2015). Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet severe malaria study. (external link)
- Kurt Hanevik; Einar Klæboe Kristoffersen; Steinar Sørnes et al. (2012). Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. (external link)
- Kristine Mørch; Kurt Hanevik; Guri Rørtveit et al. (2009). Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. (external link)
- Åsmund Heggheim; Bjørn Blomberg; Kristine Mørch (2015). Beredskap ved alvorlig malaria. (external link)
- Karolina Rembeck; Jesper Waldenström; Kristoffer Hellstrand et al. (2014). Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. (external link)
- Jesper Waldenström; Martti A. Färkkilä; Karolina Rembeck et al. (2016). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. (external link)
- Bjørn Blomberg; Karl Erik Muller; Lars Helgeland et al. (2019). En mann i 80-årene med leddgikt og vedvarende feber. (external link)
- Lucy J Robertson; K Hanevik; Angel A Escobedo et al. (2010). Giardiasis ? why do the symptoms sometimes never stop?. (external link)
- Sabrina John Moyo; Joel Manyahi; Bjørn Blomberg et al. (2020). Bacteraemia, malaria, and case fatality among children hospitalized with fever in Dar es Salaam, Tanzania. (external link)
- Knut-Arne Wensaas; Nina Langeland; Kurt Hanevik et al. (2012). Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. (external link)
- Åsa Alsiö; Peer Brehm Christensen; Martti Färkkilä et al. (2010). Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?. (external link)
- Peter Derek Christian Leutscher; Martin Lagging; Mads Rauning Buhl et al. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. (external link)
- Magdalena Ydreborg; Vera Lisovskaja; Martin Lagging et al. (2014). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (external link)
- Karolina Rembeck; Åsa Alsiö; Peer Brehm Christensen et al. (2012). Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. (external link)
- Annette Onken; Sabrina John Moyo; Mohammed Khamis Miraji et al. (2024). Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. (external link)
- Christel Gill Haanshuus; Kristine Mørch (2020). Detection of remaining Plasmodium DNA and gametocytes during follow up after curative malaria treatment among returned travellers in Norway. (external link)
- Åsa Alsiö; Anna-Maria Jannesson; Nina Langeland et al. (2012). Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. (external link)
- Siri Kratter Abrahamsen; Cathrine Ingebjørg Nødtvedt Haugen; Priscilla Rupali et al. (2013). Fever in the tropics: aetiology and case-fatality - a prospective observational study in a tertiary care hospital in South India. (external link)
- Kristine Mørch; Gunhild Holmaas; PS frolander et al. (2015). Severe human Babesia divergens infection in Norway. (external link)
- Court Pedersen; Åsa Alsiö; Martin Lagging et al. (2011). Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. (external link)
- Maria Lindh; Anders Eilard; Martti Färkkilä et al. (2011). Hepatitis C treatment response kinetics and impact of baseline predictors. (external link)
- Tilman Lingscheid; Florian Kurth; Jan Clerinx et al. (2017). Schistosomiasis in european travelers and migrants: Analysis of 14 years tropnet surveillance data. (external link)
- Kristine Mørch; Anand Manoharan; Sara Chandy et al. (2023). Clinical features and risk factors for death in acute undifferentiated fever: A prospective observational study in rural community hospitals in six states of India. (external link)
- Martin Lagging; Nina Langeland; Court Pedersen et al. (2008). Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. (external link)
- Eli Ben-Chetrit; Tamar Lachish; Kristine Mørch et al. (2015). Schistosomiasis in pregnant travelers: A case series. (external link)
- Knut-Arne Wensaas; Kurt Hanevik; Trygve Hausken et al. (2016). Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis. (external link)
- Florian Kurth; Michel Develoux; Matthieu Mechain et al. (2017). Severe malaria in Europe: an 8-year multi-centre observational study. (external link)
- Åsa Alsiö; Karolina Rembeck; Galia Askarieh et al. (2012). Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. (external link)
- Angel A Escobedo; P Almirall; Lucy J Robertson et al. (2010). Giardiasis: the ever-present threat of a neglected disease. (external link)
- Kristine Mørch; Kurt Hanevik; Lucy J. Robertson et al. (2008). Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. (external link)
- Karolina Rembeck; Cristina Maglio; Martin Lagging et al. (2012). PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. (external link)
- Gunnhild Sellevoll Hunskår; Nina Langeland; Knut-Arne Wensaas et al. (2012). The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. (external link)
- Trygve Kristiansen; Frank O. Pettersen; Tore Lier et al. (2021). Schistosomiasis hos norske studenter etter opphold i Afrika. (external link)
- Karl Erik Muller; Bjørn Blomberg; Marit Gjerde Tellevik et al. (2021). Leishmaniasis i Norge. (external link)
- Jesper Waldenström; Kristina Nyström; Staffan Nilsson et al. (2020). The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. (external link)
- Sara Chandy; Lokeshwaran Kirubanandhan; Priya Hemavathy et al. (2017). Serovar prevalence of leptospira in semirural India and the development of an igm-based indirect ELISA. (external link)
- Kristine Mørch; Anand Manoharan; Sara Chandy et al. (2017). Acute undifferentiated fever in India: A multicentre study of aetiology and diagnostic accuracy. (external link)
Conference abstract
- Karolina Rembeck; Asa Alsio; Peer B. Christensen et al. (2011). Impact of obesity on the bioavailability of peginterferon-alpha 2A and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. (external link)
- Karolina Rembeck; Magnus Lindh; Court Pedersen et al. (2012). Impact of Inosine Triphosphatase (ITPA) Gene Variants on Anemia, Ribavirin Concentrations, and Outcome During Therapy for HCV Genotype 2/3. (external link)
- Johan Westin; Martin Lagging; Carsten Pedersen et al. (2008). Twelve weeks of treatment is insufficient for HCV genotype 2 and 3 infected patients with steatosis. (external link)
- Peer B. Christensen; Åsa Alsiö; Mads Rauning Buhl et al. (2008). Ribavirin concentration at week four is an independend predictor for sustained virological response after treatment of hepatitis C genotype 2/3 (NORDynamic trial). (external link)
- Peter Derek Christian Leutscher; Mads Rauning Buhl; Martin Lagging et al. (2009). EVALUATION OF THE ROUTINE MEDICAL INTERVIEW TO IDENTIFY HEPATITIS C PATIENTS DEVELOPING MAJOR DEPRESSION DURING PEGINTERFERON ALFA-2A PLUS RIBAVIRIN TREATMENT USING THE MAJOR DEPRESSION INVENTORY. (external link)
- Martin Lagging; Carsten Pedersen; Mads Rauning Buhl et al. (2007). Comparison of peginterferon alpha-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (external link)
- Asa Alsio; Nina Langeland; Court Pedersen et al. (2010). IMPORTANCE OF HCV CORE ANTIGEN BELOW 0.2 PG/ML DAY 3 IN SHORT-TERM PEG-INTERFERON THERAPY FOR CHRONIC GENOTYPE2/3 INFECTION. (external link)
- Martin Lagging; Court Pedersen; Mads Rauning Buhl et al. (2007). Peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (external link)
- Magdalena Ydreborg; Martin Lagging; Gunnar P. Norkrans et al. (2012). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (external link)
Letter to the editor
- Martin Lagging; Åsa Alsiö; Nina Langeland et al. (2011). Early determination of Hepatitis C virus RNA may help to decide the duration of therapy for chronic Hepatitis C virus genotype 2/3 infection. (external link)
- Lucy Robertson; Kristoffer Tysnes; Kurt Hanevik et al. (2015). Hund som Giardia-kilde i Bergen i 2004 - barking up the wrong tree?. (external link)
- Martin Lagging; Nina Langeland; Court Pedersen et al. (2008). Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. (external link)